Back to Search
Start Over
Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent Model
- Source :
- Journal of Biological Chemistry. 287:44526-44535
- Publication Year :
- 2012
- Publisher :
- Elsevier BV, 2012.
-
Abstract
- Nonalcoholic steatohepatitis (NASH) is a disorder characterized by simultaneous fat accumulation and chronic inflammation in the liver. In this study, Pin1 expression was revealed to be markedly increased in the livers of mice with methionine choline-deficient (MCD) diet-induced NASH, a rodent model of NASH. In addition, Pin1 KO mice were highly resistant to MCD-induced NASH, based on a series of data showing simultaneous fat accumulation, chronic inflammation, and fibrosis in the liver. In terms of Pin1-induced fat accumulation, it was revealed that the expression levels of peroxisome proliferator-activated receptor α and its target genes were higher in the livers of Pin1 KO mice than in controls. Thus, resistance of Pin1 KO mice to hepatic steatosis is partially attributable to the lack of Pin1-induced down-regulation of peroxisome proliferator-activated receptor α, although multiple other mechanisms are apparently involved. Another mechanism involves the enhancing effect of hematopoietic Pin1 on the expressions of inflammatory cytokines such as tumor necrosis factor and monocyte chemoattractant protein 1 through NF-κB activation, eventually leading to hepatic fibrosis. Finally, to distinguish the roles of hematopoietic or nonhematopoietic Pin1 in NASH development, mice lacking Pin1 in either nonhematopoietic or hematopoietic cells were produced by bone marrow transplantation between wild-type and Pin1 KO mice. The mice having nonhematopoietic Pin1 exhibited fat accumulation without liver fibrosis on the MCD diet. Thus, hepatic Pin1 appears to be directly involved in the fat accumulation in hepatocytes, whereas Pin1 in hematopoietic cells contributes to inflammation and fibrosis. In summary, this is the first study to demonstrate that Pin1 plays critical roles in NASH development. This report also raises the possibility that hepatic Pin1 inhibition to the appropriate level might provide a novel therapeutic strategy for NASH.
- Subjects :
- Male
Inflammation
Fatty Liver/*enzymology/genetics/pathology
Biology
digestive system
Biochemistry
Proinflammatory cytokine
Mice
Non-alcoholic Fatty Liver Disease
Fibrosis
medicine
Animals
Humans
Molecular Biology
Mice, Knockout
Peptidylprolyl isomerase
Peptidylprolyl Isomerase/genetics/*metabolism
Fatty liver
Liver/enzymology
nutritional and metabolic diseases
Cell Biology
Peptidylprolyl Isomerase
medicine.disease
digestive system diseases
Fatty Liver
Mice, Inbred C57BL
NIMA-Interacting Peptidylprolyl Isomerase
Disease Models, Animal
Metabolism
Liver
Immunology
Cancer research
Female
Tumor necrosis factor alpha
Steatosis
medicine.symptom
Hepatic fibrosis
Subjects
Details
- ISSN :
- 00219258
- Volume :
- 287
- Database :
- OpenAIRE
- Journal :
- Journal of Biological Chemistry
- Accession number :
- edsair.doi.dedup.....7de406999c906babd08d284ed6eb2fa8